kabutan

CellSeed Inc.(7776) Summary

7776
TSE Growth
CellSeed Inc.
265
JPY
-3
(-1.12%)
Dec 5, 11:29 am JST
1.70
USD
Dec 4, 9:29 pm EST
Result
PTS
outside of trading hours
263.2
Dec 5, 11:29 am JST
Summary Chart Historical News Financial Result
PER
PBR
7.05
Yield
ー%
Margin Trading Ratio
47,560.00
Stock Price
Dec 5, 2025
Opening Dec 5, 9:00 am
273 JPY 1.75 USD
Previous Close Dec 4
268 JPY 1.72 USD
High Dec 5, 9:00 am
274 JPY 1.76 USD
Low Dec 5, 10:34 am
260 JPY 1.67 USD
Volume
524,800
Trading Value
0.14B JPY 0.90M USD
VWAP
265.78 JPY 1.71 USD
Minimum Trading Value
26,500 JPY 170 USD
Market Cap
9.19B JPY 0.06B USD
Number of Trades
434
Liquidity & Number of Trades
As of Dec 5, 2025
Liquidity
High
1-Year Average
1,268
1-Year High Mar 27, 2025
29,466
Margin Trading
Date Short Interest Long Margin Positions Ratio
Nov 28, 2025 0 3,145,700
Nov 21, 2025 26,200 3,590,400 137.04
Nov 14, 2025 0 4,136,500
Nov 7, 2025 0 4,205,100
Oct 31, 2025 0 4,253,900
Company Profile
CellSeed Inc. is a biotech venture originating from Tokyo Women's Medical University, primarily focused on cell sheet regenerative medicine and regenerative medicine support.
Sector
Precision Instruments
CellSeed Inc. is based on cell sheet engineering technology and aims to promote the global adoption of cell sheet regenerative medicine. The company operates in two main areas: regenerative medicine support and cell sheet regenerative medicine. In the regenerative medicine support business, CellSeed Inc. conducts research, development, manufacturing, and sales of temperature-responsive cell culture equipment and related products. The cell sheet regenerative medicine business involves the research, development, manufacturing, and sales of cell sheet regenerative medicine products and their applications.